TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
TuHURA BIOSCIENCES, INC./NV (HURA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 3.38 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.38M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.02M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.26M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.31M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-06-30 | 3.38M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 3.02M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 3.26M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 2.31M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 2.31M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 2.17M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 2.27M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 4.00K shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 116.00K shares 10-K · filed 2024-10-07 |
| 2024-03-31 | 102.00K shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 101.00K shares 10-Q · filed 2024-02-14 |
| 2023-09-30 | 105.00K shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 80.00K shares 10-K · filed 2023-09-18 |
| 2023-03-31 | 72.00K shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 114.00K shares 10-Q · filed 2023-02-14 |
| 2022-09-30 | 4.85M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 4.61M shares 10-K · filed 2022-09-27 |
| 2022-03-31 | 4.06M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 3.63M shares 10-Q · filed 2022-02-11 |
| 2021-09-30 | 3.05M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 2.53M shares 10-K · filed 2021-09-28 |
| 2021-03-31 | 2.13M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.22K shares 10-Q · filed 2021-02-12 |
| 2020-09-30 | 828.00 shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 701.69K shares 10-K · filed 2020-09-18 |
| 2017-12-31 | 943.73K shares 10-Q · filed 2018-02-14 |
| 2017-09-30 | 837.78K shares 10-Q · filed 2017-11-09 |
| 2015-03-31 | 2.75M shares 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |